Experimental 'Armored' cell shot targets solid cancers in tiny safety trial
NCT ID NCT07479667
First seen Apr 06, 2026 · Last updated May 16, 2026 · Updated 8 times
Summary
This early study is testing a single injection of special immune cells (dendritic cells) that are 'armored' with antibodies to see if they are safe for people with solid tumors like pancreatic, colorectal, or stomach cancer. Only 8 adults who have already had surgery and chemotherapy are taking part. The main goal is to check for side effects, not to cure the cancer.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SOLID CANCERS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Shanghai Mengchao Tumor Hospital
RECRUITINGShanghai, China
Conditions
Explore the condition pages connected to this study.